Clinical Trials Browser

Phase 3 × capivasertib × 90 days × Clear all

NCT04862663 2026-05-27

CAPItello-292

Phase 3 Recruiting

Locally Advanced (Inoperable) or Metastatic Breast Cancer

NCT06982521 2026-05-08

ReDiscover-2

Phase 3 Recruiting

Breast Neoplasms

NCT04493853 2026-05-05

CAPItello-281

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT04305496 2026-04-30

CAPItello-291

Phase 3 Active not recruiting

818 enrolled 19 charts 2 FDA

Locally Advanced (Inoperable) or Metastatic Breast Cancer

NCT06764186 2026-04-08

CAPItana

Phase 3 Active not recruiting

Breast Neoplasms

NCT06635447 2026-03-27

CAPItrue

Phase 3 Active not recruiting

Breast Neoplasms, Disease Progression